SEARCH

SEARCH BY CITATION

References

  • 1
    MacGillivray I, Davey DA. Classification of hypertensive disorders of pregnancy. In: Sharp F, Symonds EM, editors. Proceedings of the 16th Study Group of RCOG. Ithaca, NY: Perinatology Press; 1986. pp. 4018.
  • 2
    Hay JE. Liver disease in pregnancy. Hepatology 2008;47:106776.
  • 3
    Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol 2009;20:1422.
  • 4
    Stennett AK, Khalil RA. Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res 2006;3:13148.
  • 5
    Gruslin A, Lemyre B. Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol 2011;25:491507.
  • 6
    Andersgaard AB, Acharya G, Mathiesen EB, Johnsen SH, Straume B, Øian P. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study. Am J Obstet Gynecol 2012;206:143.e1143.e8.
  • 7
    Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366:1797803.
  • 8
    Ghio A, Bertolotto A, Resi V, Volpe L, Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem 2011;55:13353.
  • 9
    Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 2010;37:23953.
  • 10
    Sweeney M, Wareing M, Mills TA, Baker PN, Taggart MJ. Characterisation of tone oscillations in placental and myometrial arteries from normal pregnancies and those complicated by pre-eclampsia and growth restriction. Placenta 2008;29:35665.
  • 11
    Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEngoglin) in preeclampsia—a step forward but not the definitive answer. J Reprod Immunol 2009;82:10611.
  • 12
    Wang Y, Lewis DF, Gu Y, Zhang Y, Alexander JS, Granger DN. Placental trophoblast-derived factors diminish endothelial barrier function. J Clin Endocrinol 2004;89:24218.
  • 13
    Dunne F. Type 2 diabetes and pregnancy. Semin Fetal Neonatal Med 2005;10:3339.
  • 14
    Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003;101:131932.
  • 15
    Sohlberg S, Stephansson O, Cnattingius S, Wikstrom AK. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens 2012;25:1205.
  • 16
    Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003;19:25970.
  • 17
    Montes A, Walden CE, Knopp RH, Cheung M, Chapman MB, Albers JJ. Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of ‘prelipemia’. Arteriosclerosis 1984;4:40717.
  • 18
    Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:64958.
  • 19
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:9921005.
  • 20
    Robinson NJ, Minchell LJ, Myers JE, Hubel CA, Crocker IP. A potential role for free fatty acids in the pathogenesis of preeclampsia. J Hypertens 2009;27:1293302.
  • 21
    Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael CJ. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? Hypertension 1999;17:130715.
  • 22
    Belo L, Gaffney D, Caslake M, Santos-Silva A, Pereira-Leite L, Quintanilha A, et al. Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 2004;112:915.
  • 23
    De J, Mukhopadhyay AK, Saha PK. Study of serum lipid profile in pregnancy induced hypertension. Indian J Clin Biochem 2006;21:1658.
  • 24
    Francoual J, Audibert F, Claise C, Chalas J, Trioche P, Frydman R, et al. Implication of apolipoprotein E and the L-arginine-nitric oxide system in preeclampsia. Hypertens Pregnancy 1999;18:22937.
  • 25
    Gratacós E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996;75:896901.
  • 26
    Gratacós E, Casals E, Gómez O, Llurba E, Mercader I, Cararach V, et al. Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia. BJOG 2003;110:4004.
  • 27
    Harsem NK, Roald B, Braekke K, Staff AC. Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia. Placenta 2007;28:95864.
  • 28
    Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism 1998;47:12818.
  • 29
    Khaliq F, Singhal U, Arshad Z, Hossain MM. Study of serum lipid and lipoprotein in pre-eclampsia with special reference to parity. Indian J Physiol Pharmacol 2000;44:1926.
  • 30
    Kharb S, Gulati N, Singh V, Singh GP. Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 1998;46:23840.
  • 31
    Lei Q, Lv LJ, Zhang BY, Wen JY, Liu GC, Lin XH, et al. Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia. J Hum Hypertens 2011;25:117.
  • 32
    Llurba E, Gratacós E, Martín-Gallán P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004;37:55770.
  • 33
    Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 1995;102:5307.
  • 34
    Mikhail MS, Basu J, Palan PR, Furgiuele J, Romney SL, Anyaegbunam A. Lipid profile in women with preeclampsia: relationship between plasma triglyceride levels and severity of preeclampsia. J Assoc Acad Minor Phys 1995;6:435.
  • 35
    Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 1997;46:9637.
  • 36
    Ozan H, Esmer A, Kolsal N, Copur OU, Ediz B. Plasma ascorbic acid level and erythrocyte fragility in preeclampsia and eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;71:3540.
  • 37
    Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;179:160511.
  • 38
    Raijmakers MT, van Tits BJ, Hak-Lemmers HL, Roes EM, Steegers EA, Peters WH. Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet Gynecol Scand 2004;83:11737.
  • 39
    Sahu S, Abraham R, Vedavalli R, Daniel M. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol 2009;53:3659.
  • 40
    Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisløff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999;78:1917.
  • 41
    Spaan JJ, Houben AJ, Musella A, Ekhart T, Spaanderman ME, Peeters LL. Insulin resistance relates to microvascular reactivity 23 years after preeclampsia. Microvasc Res 2010;80:41721.
  • 42
    Vanderjagt DJ, Patel RJ, El-Nafaty AU, Melah GS, Crossey MJ, Glew RH. High-density lipoprotein and homocysteine levels correlate inversely in preeclamptic women in northern Nigeria. Acta Obstet Gynecol Scand 2004;83:53642.
  • 43
    Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999;67:14755.
  • 44
    Williams MA, Woelk GB, King IB, Jenkins L, Mahomed K. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens 2003;16:66572.
  • 45
    Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001;108:10817.
  • 46
    Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:57481.
  • 47
    Setareh A, Mitra MG, Sedigheh B, Shoaleh S, Vahid Y, Siroos S. Maternal plasma lipid concentrations in first trimester of pregnancy and risk of severe preeclampsia. Pakistan J Med Sci 2009;25:5637.
  • 48
    Takahashi WH, Martinelli S, Khoury MY, Lopes RGC, Garcia SAL, Lippi UG. Assessment of serum lipids in pregnant women aged over 35 years and their relation with pre-eclampsia. Einstein 2008;6:637.
  • 49
    Ziaei S, Bonab KM, Kazemnejad A. Serum lipid levels at 28–32 weeks gestation and hypertensive disorders. Hypertens in Pregnancy 2006;25:310.
  • 50
    Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [www.cochrane-handbook.org]. Accessed 15 February 2013.
  • 51
    Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, et al. Multilayer film elements for clinical analysis. Clin Chem 1978;24:134850.
  • 52
    Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clin Chim Acta 1981;115:15561.